Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Precision Medicine and Targeted Therapies in Breast Cancer.

Greenwalt I, Zaza N, Das S, Li BD.

Surg Oncol Clin N Am. 2020 Jan;29(1):51-62. doi: 10.1016/j.soc.2019.08.004. Epub 2019 Oct 29. Review.

PMID:
31757313
2.

Consequences of the 340B Drug Pricing Program.

Ross SL, Li BD.

N Engl J Med. 2018 May 24;378(21):2053. doi: 10.1056/NEJMc1802999. No abstract available.

PMID:
29792408
3.

Viral mimic polyinosine-polycytidylic acid potentiates liver injury in trichloroethylene-sensitized mice - Viral-chemical interaction as a novel mechanism.

Zhang C, Yu Y, Yu JF, Li BD, Zhou CF, Yang XD, Wang X, Wu C, Shen T, Zhu QX.

Ecotoxicol Environ Saf. 2018 Jul 15;155:101-108. doi: 10.1016/j.ecoenv.2018.02.056. Epub 2018 Mar 3.

PMID:
29510304
4.

Comparison of the Efficacy of Different Drugs on Non-Motor Symptoms of Parkinson's Disease: a Network Meta-Analysis.

Li BD, Cui JJ, Song J, Qi C, Ma PF, Wang YR, Bai J.

Cell Physiol Biochem. 2018;45(1):119-130. doi: 10.1159/000486252. Epub 2018 Jan 15.

5.

Adverse effects produced by different drugs used in the treatment of Parkinson's disease: A mixed treatment comparison.

Li BD, Bi ZY, Liu JF, Si WJ, Shi QQ, Xue LP, Bai J.

CNS Neurosci Ther. 2017 Oct;23(10):827-842. doi: 10.1111/cns.12727. Epub 2017 Sep 4.

6.

[Study on seasonal characteristics and pathogenic distribution of influenza in Gansu province of China].

Yang XT, Liu XF, He J, Yu DS, Liu DP, Li HY, Li BD, Bai YN.

Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jun 10;38(6):763-766. doi: 10.3760/cma.j.issn.0254-6450.2017.06.015. Chinese.

PMID:
28647979
7.

[Role of complement regulatory protein CD55 in the liver immune injury of trichloroethylene-sensitized mice].

Wang X, Zhang C, Yang XD, Li BD, Zang DD, Yang P, Zhang JX, Zhu QX.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2017 Apr 20;35(4):246-250. doi: 10.3760/cma.j.issn.1001-9391.2017.04.002. Chinese.

PMID:
28614920
8.

[The effect of complement C3a receptor antagonist in the kidney immune injury in trichloroethylene-sensitized mice].

Yang P, Zang DD, Yang XD, Li BD, Wang X, Zhang JX, Zhu QX.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2017 Mar 20;35(3):161-165. doi: 10.3760/cma.j.issn.1001-9391.2017.03.001. Chinese.

PMID:
28511297
9.

Breast cancer outcomes in a population with high prevalence of obesity.

Herlevic VC, Mowad R, Miller JK, Darensburg NA, Li BD, Kim RH.

J Surg Res. 2015 Oct;198(2):371-6. doi: 10.1016/j.jss.2015.03.088. Epub 2015 Apr 7.

PMID:
25959832
10.

Overexpression of eukaryotic initiation factor 4E is correlated with increased risk for systemic dissemination in node-positive breast cancer patients.

Yin X, Kim RH, Sun G, Miller JK, Li BD.

J Am Coll Surg. 2014 Apr;218(4):663-71. doi: 10.1016/j.jamcollsurg.2013.12.020. Epub 2014 Jan 4.

PMID:
24491247
11.

Effect of January vacations and prior night call status on resident ABSITE performance.

Sugar JG, Chu QD, Cole PA, Li BD, Kim RH.

J Surg Educ. 2013 Nov-Dec;70(6):720-4. doi: 10.1016/j.jsurg.2013.06.013. Epub 2013 Jul 12. Review.

PMID:
24209647
12.

Effect of miR27a on proliferation and invasion in colonic cancer cells.

Gao Y, Li BD, Liu YG.

Asian Pac J Cancer Prev. 2013;14(8):4675-8.

13.

[Characterization of human rhinovirus in children with acute respiratory infections in Gansu Province during 2011].

Zhang S, Mao NY, Yu DS, Huang GH, Li XX, Li HY, Li BD, Zhang Y, Cui AL, Chen XP, Yu AL, Xu WB.

Bing Du Xue Bao. 2013 May;29(3):273-9. Chinese.

PMID:
23905470
14.

Does obesity have an effect on outcomes in triple-negative breast cancer?

Mowad R, Chu QD, Li BD, Burton GV, Ampil FL, Kim RH.

J Surg Res. 2013 Sep;184(1):253-9. doi: 10.1016/j.jss.2013.05.037. Epub 2013 Jun 2.

PMID:
23768767
15.

Is chronic kidney disease an independent risk factor for mortality in breast cancer?

Dubose AC, Chu QD, Li BD, Kim RH.

J Surg Res. 2013 Sep;184(1):260-4. doi: 10.1016/j.jss.2013.04.035. Epub 2013 May 9.

PMID:
23688790
16.

Is baseline bone imaging in high-risk breast cancer patients justified?

Ampil FL, Li BD, Burton GV, Kim RH, Baluna RG, Chu Q.

Breast J. 2012 Nov-Dec;18(6):639-40. doi: 10.1111/tbj.12021. Epub 2012 Sep 26. No abstract available.

PMID:
23009654
17.

Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.

Chu QD, Sun G, Pope M, Luraguiz N, Curiel DT, Kim R, Li BD, Mathis JM.

Surgery. 2012 Sep;152(3):441-8. doi: 10.1016/j.surg.2012.05.040. Epub 2012 Jul 31.

18.

Outcome for patients with triple-negative breast cancer is not dependent on race/ethnicity.

Chu QD, Henderson AE, Ampil F, Li BD.

Int J Breast Cancer. 2012;2012:764570. doi: 10.1155/2012/764570. Epub 2012 May 8.

19.

[A controlled study on the treatment of acute progressive cerebral infarction by continuous anticoagulation with small doses of heparin].

Wang ZY, Wang LC, Chen C, Ge JY, Gao YS, Lin SF, Yan RP, Li BD.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 May;24(5):290-3. Chinese.

20.

The chemokine receptor CXCR4 as a novel independent prognostic marker for node-positive breast cancer patients.

Parker CC, Kim RH, Li BD, Chu QD.

J Surg Oncol. 2012 Sep 15;106(4):393-8. doi: 10.1002/jso.23113. Epub 2012 Apr 3.

PMID:
22473623
21.

Should a routine metastatic workup be performed for all patients with pathologic N2/N3 breast cancer?

Chu QD, Henderson A, Kim RH, Miller JK, Burton G, Ampil F, Li BD.

J Am Coll Surg. 2012 Apr;214(4):456-61; discussion 461-2. doi: 10.1016/j.jamcollsurg.2011.12.014. Epub 2012 Feb 17.

PMID:
22342788
22.

Establishment of a mammary carcinoma cell line from Syrian hamsters treated with N-methyl-N-nitrosourea.

Coburn MA, Brueggemann S, Bhatia S, Cheng B, Li BD, Li XL, Luraguiz N, Maxuitenko YY, Orchard EA, Zhang S, Stoff-Khalili MA, Mathis JM, Kleiner-Hancock HE.

Cancer Lett. 2011 Dec 15;312(1):82-90. doi: 10.1016/j.canlet.2011.08.003. Epub 2011 Aug 17.

23.

Chemokine receptor CXCR4 level in primary tumors independently predicts outcome for patients with locally advanced breast cancer.

Hiller DJ, Meschonat C, Kim R, Li BD, Chu QD.

Surgery. 2011 Sep;150(3):459-65. doi: 10.1016/j.surg.2011.07.005.

PMID:
21878231
24.

Update on desmoid tumors.

Escobar C, Munker R, Thomas JO, Li BD, Burton GV.

Ann Oncol. 2012 Mar;23(3):562-9. doi: 10.1093/annonc/mdr386. Epub 2011 Aug 22. Review.

PMID:
21859899
25.

The role of chemokine receptor CXCR4 in the biologic behavior of human soft tissue sarcoma.

Kim RH, Li BD, Chu QD.

Sarcoma. 2011;2011:593708. doi: 10.1155/2011/593708. Epub 2010 Dec 22.

26.

Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.

Li BD, Sicard MA, Ampil F, Abreo F, Lilien D, Chu QD, Burton GV.

Oncology. 2010;79(1-2):3-12. doi: 10.1159/000318529. Epub 2010 Nov 3. Review.

PMID:
21051912
27.

CXCR4 as a predictive marker for locally advanced breast cancer post-neoadjuvant therapy.

Hiller DJ, Li BD, Chu QD.

J Surg Res. 2011 Mar;166(1):14-8. doi: 10.1016/j.jss.2010.04.045. Epub 2010 May 21.

PMID:
20828730
28.

The utility of a tissue slice model system to determine breast cancer infectivity by oncolytic adenoviruses.

Pennington K, Chu QD, Curiel DT, Li BD, Mathis JM.

J Surg Res. 2010 Oct;163(2):270-5. doi: 10.1016/j.jss.2010.03.072. Epub 2010 Apr 24.

29.

Chemokine receptor CXCR4 overexpression predicts recurrence for hormone receptor-positive, node-negative breast cancer patients.

Chu QD, Holm NT, Madumere P, Johnson LW, Abreo F, Li BD.

Surgery. 2011 Feb;149(2):193-9. doi: 10.1016/j.surg.2010.05.016.

PMID:
20598333
30.

Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?

Parker CC, Ampil F, Burton G, Li BD, Chu QD.

Surgery. 2010 Aug;148(2):386-91. doi: 10.1016/j.surg.2010.05.018. Epub 2010 Jul 1.

PMID:
20580045
31.

Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.

Chu QD, Burton G, Glass J, Smith MH, Li BD.

J Am Coll Surg. 2010 May;210(5):585-92, 592-4. doi: 10.1016/j.jamcollsurg.2010.01.025.

PMID:
20421009
32.

Predictive value of eIF4E reduction after neoadjuvant therapy in breast cancer.

Hiller DJ, Chu Q, Meschonat C, Panu L, Burton G, Li BD.

J Surg Res. 2009 Oct;156(2):265-9. doi: 10.1016/j.jss.2009.03.060. Epub 2009 May 3.

PMID:
19665145
33.

Citrus auraptene suppresses cyclin D1 and significantly delays N-methyl nitrosourea induced mammary carcinogenesis in female Sprague-Dawley rats.

Krishnan P, Yan KJ, Windler D, Tubbs J, Grand R, Li BD, Aldaz CM, McLarty J, Kleiner-Hancock HE.

BMC Cancer. 2009 Jul 29;9:259. doi: 10.1186/1471-2407-9-259.

34.

Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.

Flowers A, Chu QD, Panu L, Meschonat C, Caldito G, Lowery-Nordberg M, Li BD.

Surgery. 2009 Aug;146(2):220-6. doi: 10.1016/j.surg.2009.05.010.

PMID:
19628077
35.

Race/Ethnicity has no effect on outcome for breast cancer patients treated at an academic center with a public hospital.

Chu QD, Smith MH, Williams M, Panu L, Johnson LW, Shi R, Li BD, Glass J.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2157-61. doi: 10.1158/1055-9965.EPI-09-0232. Epub 2009 Jul 21.

36.

Overexpression of CXCR4 in primary tumor of patients with HER-2 negative breast cancer was predictive of a poor disease-free survival: a validation study.

Mizell J, Smith M, Li BD, Ampil F, Chu QD.

Ann Surg Oncol. 2009 Oct;16(10):2711-6. doi: 10.1245/s10434-009-0551-0. Epub 2009 Jul 11.

PMID:
19593633
37.

High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome.

Chu QD, Panu L, Holm NT, Li BD, Johnson LW, Zhang S.

J Surg Res. 2010 Apr;159(2):689-95. doi: 10.1016/j.jss.2008.09.020. Epub 2008 Oct 16.

PMID:
19500800
38.

Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast cancer.

Kleiner HE, Krishnan P, Tubbs J, Smith M, Meschonat C, Shi R, Lowery-Nordberg M, Adegboyega P, Unger M, Cardelli J, Chu Q, Mathis JM, Clifford J, De Benedetti A, Li BD.

J Exp Clin Cancer Res. 2009 Jan 9;28:5. doi: 10.1186/1756-9966-28-5. Erratum in: J Exp Clin Cancer Res. 2009;28:54.

39.

Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.

Upton B, Chu Q, Li BD.

Surg Oncol Clin N Am. 2009 Jan;18(1):145-56, ix. doi: 10.1016/j.soc.2008.08.006. Review.

PMID:
19056046
40.

A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.

Holm N, Byrnes K, Johnson L, Abreo F, Sehon K, Alley J, Meschonat C, Md QC, Li BD.

Ann Surg Oncol. 2008 Nov;15(11):3207-15. doi: 10.1245/s10434-008-0086-9. Epub 2008 Aug 22.

PMID:
18719964
41.

eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival.

Siegele B, Cefalu C, Holm N, Sun G, Tubbs J, Meschonat C, Odaka Y, DeBenedetti A, Ghali GE, Chu Q, Mathis JM, Li BD.

J Surg Res. 2008 Jul;148(1):83-9. doi: 10.1016/j.jss.2008.03.011. Epub 2008 Apr 9.

PMID:
18570935
42.

Translational research in breast cancer.

Chu QD, Holm N, Byrnes K, Li BD.

Surg Oncol Clin N Am. 2008 Apr;17(2):421-38, x. doi: 10.1016/j.soc.2007.12.006. Review.

PMID:
18375360
43.

Surgical oncology clinics of North America. Translational research in surgical oncology. Preface.

Li BD.

Surg Oncol Clin N Am. 2008 Apr;17(2):xv-xvi. doi: 10.1016/j.soc.2008.02.012. No abstract available.

PMID:
18375351
44.

Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC).

Holm NT, Abreo F, Johnson LW, Li BD, Chu QD.

Breast Cancer Res Treat. 2009 Jan;113(2):293-9. doi: 10.1007/s10549-008-9921-8. Epub 2008 Feb 13.

PMID:
18270814
45.

[The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].

Ma YL, Zheng Z, Li BD, Xie SJ, Li GX, Yan QH, Cai JH.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2007 Nov;23(11):1046-9. Chinese.

PMID:
17988589
46.
47.

A novel suicide gene therapy targeting the overexpression of eukaryotic initiation factor 4E improves survival in a rat peritoneal carcinomatosis model.

Byrnes K, Li BD, Holm N, Li J, Okadata Y, De Benedetti A, Nedeljkovic-Kurepa A, Mathis M, Chu QD.

Surgery. 2007 Aug;142(2):270-5.

PMID:
17689695
48.

Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.

Holm NT, Byrnes K, Li BD, Turnage RH, Abreo F, Mathis JM, Chu QD.

J Surg Res. 2007 Jul;141(1):53-9.

PMID:
17574038
49.

Correlation of TLK1B in elevation and recurrence in doxorubicin-treated breast cancer patients with high eIF4E overexpression.

Byrnes KW, DeBenedetti A, Holm NT, Luke J, Nunez J, Chu QD, Meschonat C, Abreo F, Johnson LW, Li BD.

J Am Coll Surg. 2007 May;204(5):925-33; discussion 933-4.

PMID:
17481512
50.

Accelerated partial breast irradiation in early-stage breast cancer.

Sanders ME, Scroggins T, Ampil FL, Li BD.

J Clin Oncol. 2007 Mar 10;25(8):996-1002. Review. Erratum in: J Clin Oncol. 2007 Aug 10;25(23):3561.

PMID:
17350949

Supplemental Content

Support Center